Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter John Whittle is active.

Publication


Featured researches published by Peter John Whittle.


Trends in Biochemical Sciences | 1990

The 3-D structure of HIV-1 proteinase and the design of antiviral agents for the treatment of AIDS

Tom L. Blundell; Risto Lapatto; Andrew F. Wilderspin; Andrew M. Hemmings; Peter M. Hobart; Dennis E. Danley; Peter John Whittle

A proteinase is essential for replication of HIV. Cloning and chemical synthesis have provided a sufficient supply of HIV-1 proteinase for the determination of its three-dimensional structure. Analogies between the structures of HIV-1 proteinase and the mammalian enzyme renin, which is involved in the control of blood pressure, have given important clues concerning the design of specific inhibitors that have antiviral activity.


Bioorganic & Medicinal Chemistry Letters | 1999

A new class of selective and potent inhibitors of neuronal nitric oxide synthase.

John A. Lowe; Weimin Qian; Robert A. Volkmann; Steven D. Heck; Jolanta Nowakowski; Robert B. Nelson; Charles E. Nolan; Dane Liston; Karen M. Ward; Stevin H. Zorn; Celeste Johnson; Michelle Vanase; W. Stephen Faraci; Kimberly A. Verdries; James Baxter; Shawn D. Doran; Martin Sanders; Mike Ashton; Peter John Whittle; Mark H. Stefaniak

The synthesis and SAR of a series of 6-(4-(substituted)phenyl)-2-aminopyridines as inhibitors of nitric oxide synthase are described. Compound 3a from this series shows potent and selective inhibition of the human nNOS isoform, with pharmacokinetics sufficient to provide in vivo inhibition of nNOS activity.


Archive | 1990

Three-dimensional Structure and Evolution of HIV-1 Protease

Andrew F. Wilderspin; Duncan J. H. Gaskin; Risto Lapatto; Tom L. Blundell; Andrew Hemmings; John P. Overington; Jim E. Pitts; S.P. Wood; Zhang-Yang Zhu; Laurence H. Pearl; Dennis E. Danley; Kieran Francis Geoghegan; Stephen Hawrylik; S.Edward Lee; Kathryn Shield; Peter Hobart; James R. Merson; Peter John Whittle

HIV-1 proteinase processes its virally encoded polyproteins into mature structural proteins and enzymes that are essential for viral propagation. As a consequence the proteinase is an attractive target for prospective antiviral agents for the treatment of AIDS, and knowledge of its tertiary structure an important step in drug design. Following the observation (Toh et al. 1985) that retroviral proteinases shared a highly conserved sequence Asp-Thr/Ser-Gly with the pepsins, it has been hypothesised (Pearl and Taylor, 1987; Blundell et al. 1988) on the basis of sequence analysis and modelling studies that these enzymes exist as dimers closely similar in three-dimensional structure to the ancestral dimeric proteinase suggested for the aspartic proteinases (Tang et al. 1978). This has now been confirmed, first by X-ray analysis of a synthetic HIV-1 proteinase in the laboratory of Wlodawer (Weber et al. 1989) and then for a recombinant enzyme in our own laboratories (Lapatto et al. 1989). These X-ray structure analyses indicated that the overall fold of the HIV-1 proteinase closely resembled that of the RSV-proteinase (Miller et al., 1989). The Asp-Thr-Gly sequences adopt a conformation closely similar to that of the pepsin-like aspartic proteinases but organised symmetrically in the dimer about the crystallographic 2-fold axis. However, the N- and C-termini together form an intermolecular four-stranded sheet, which is central to the stability of the dimer, in contrast to the inter-subunit sheet of the pepsins, which has six antiparallel strands arranged around the pseudo dyad.


Nature | 1989

X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes.

Risto Lapatto; Tom L. Blundell; Andrew Hemmings; John P. Overington; Andrew F. Wilderspin; Stephen A. Wood; James R. Merson; Peter John Whittle; Dennis E. Danley; Kieran F. Geoghegan; Steven J. Hawrylik; Shih-Jen Edward Lee; Kathryn G. Scheld; Peter Hobart


Annual Review of Biophysics and Biomolecular Structure | 1994

Protein Structure-Based Drug Design

Peter John Whittle; Tom L. Blundell


Archive | 1997

6-phenylpyridyl-2-amine derivatives

John A. Lowe; Peter John Whittle


Archive | 1997

6-phenyl-pyridin-2-ylamine derivatives

John A. Lowe; Peter John Whittle


Archive | 1983

Antifungal 1-aryl-1-fluoroalkyl-2-(1H-1,2,4-triazol-1-yl)ethanols

Kenneth Richardson; Peter John Whittle


Archive | 1983

Antifungal 2-aryl-1,1-difluoro-3-(1H-1,2,4-triazol-1-yl)2-propanols

Kenneth Richardson; Peter John Whittle


Archive | 1983

Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols

Kevin Cooper; Kenneth Richardson; Peter John Whittle

Collaboration


Dive into the Peter John Whittle's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew F. Wilderspin

Laboratory of Molecular Biology

View shared research outputs
Top Co-Authors

Avatar

Risto Lapatto

Laboratory of Molecular Biology

View shared research outputs
Researchain Logo
Decentralizing Knowledge